Elixinol Wellness Limited
ELLXF
$0.012
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 77.29% | 41.17% | 2.24% | 21.45% | 33.04% |
| Total Depreciation and Amortization | 73.58% | 80.76% | 87.52% | 28.89% | -10.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -86.74% | -99.10% | -109.35% | -55.53% | 36.81% |
| Change in Net Operating Assets | -258.68% | -155.85% | 965.12% | 965.12% | 965.12% |
| Cash from Operations | -25.98% | -25.03% | -22.09% | 42.30% | 68.31% |
| Capital Expenditure | -406.41% | -558.62% | -843.59% | -519.44% | -136.36% |
| Sale of Property, Plant, and Equipment | -- | -88.33% | -86.96% | -88.32% | -89.43% |
| Cash Acquisitions | -1,292.27% | -2,135.29% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 277.11% | 224.08% | 191.23% | 120.76% | -8.66% |
| Cash from Investing | 93.66% | 108.61% | 117.22% | 74.06% | -21.21% |
| Total Debt Issued | 187.00% | 287.00% | -- | -- | -- |
| Total Debt Repaid | -41.06% | -11.05% | 20.14% | 11.04% | 2.51% |
| Issuance of Common Stock | 107.07% | 73.84% | 40.62% | 140.62% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -183.42% | -140.95% | -98.49% | -198.49% | -- |
| Cash from Financing | 136.30% | 111.51% | 81.44% | 587.68% | 307.27% |
| Foreign Exchange rate Adjustments | -129.33% | -116.86% | -110.86% | -59.33% | 440.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.25% | 82.03% | 63.45% | 74.95% | 79.47% |